Five health investors explain how they assess whether good regulatory processes are in place before they invest and how the current regulatory environment affects their decision-making process.
- Damian Lamb, Managing Director, Genesys Capital
- Nilay Thakar, Associate, ARCH Venture Partners
- James Hardiman, Partner, DCVC
- Scott Kaplanis, Partner, Epic Capital Management
- Brenda Irwin, Managing Partner, Relentless Venture Fund